Cocrystal Pharma Depreciation & Amortization 2011-2026 | COCP

Annual Depreciation & Amortization Cocrystal Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
72 K	126 K	189 K	185 K	190 K	157 K	98 K	50 K	101 K	201 K	192 K	199 K	236 K	139 K	532 K	433 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
532 K	50 K	194 K

Quarterly Depreciation & Amortization Cocrystal Pharma

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12 K	-	-	25 K	-	-	-	35 K	-	-	-	49 K	-	47 K	90 K	46 K	-	142 K	92 K	45 K	-	44 K	36 K	30 K	-	24 K	22 K	23 K	-	11 K	6 K	6 K	-	77 K	52 K	26 K	-	159 K	109 K	56 K	-	133 K	88 K	45 K	-	154 K	107 K	57 K	-	178 K	119 K	129 K	-	361 K	239 K	115 K	-	372 K	167 K	76.4 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
372 K	6 K	90.1 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	1.3 M	$ 1.72	4.57 %	$ 201 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Celldex Therapeutics CLDX	3.38 M	$ 31.9	3.39 %	$ 2.12 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Compugen Ltd. CGEN	475 K	$ 2.68	0.75 %	$ 250 M	Israel
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.75	9.37 %	$ 34.3 M	Israel
Esperion Therapeutics ESPR	105 K	$ 3.13	0.32 %	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 31.76	1.5 %	$ 855 M	USA
Forte Biosciences FBRX	64 K	$ 22.94	4.54 %	$ 297 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Hutchison China MediTech Limited HCM	13.3 M	$ 11.93	1.53 %	$ 10.2 B	China
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Heron Therapeutics HRTX	2.31 M	$ 0.92	3.78 %	$ 153 M	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	5.37 M	$ 14.69	-1.36 %	$ 211 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.42	-0.73 %	$ 5.63 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA